Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Global Drug Delivery Challenges Explained

YouTube video thumbnail

In this episode of Bio Break, Nick Allan and Nigel Syrotuck dive into the surprising realities of global drug delivery. While medical devices often dominate development conversations, the way drugs are delivered across regions can dramatically change how treatments succeed — or fail.

Nigel reflects on a trip to Italy where food sparked thoughts about oral drug delivery. In regions like Italy, pills and tablets are the most common approach. Larger countries also tend to prefer simple, scalable methods such as pills or injections. By contrast, smaller regions may be more open to specialized treatments that require more time or unique handling.

Regional Differences in Drug Delivery

Drug delivery methods are influenced not just by culture, but also by economics, insurance systems, and infrastructure. For example, biosimilars are more readily accepted in some countries depending on reimbursement structures. Meanwhile, large-scale programs — such as vaccine rollouts — highlight how fragile supply chains can be.

Cold Chain and Pandemic Lessons

Certain drugs, including attenuated vaccines, require strict cold chain maintenance. In developing regions, this presents a major challenge. The COVID-19 pandemic underscored this issue when millions of doses expired due to distribution and storage limitations. As Nick and Nigel note, a drug designed for one part of the world may face barriers to adoption in another, depending on the delivery method.

One engineer works hands-on with this board's internals, carrying it from design through bring-up

When one team designs, lays out, and brings up a board, knowledge sticks. Splitting that work across specialists looks efficient but creates the risk it’s meant to avoid.

AI coding agents support this engineer as he reviews code and a workflow diagram on a call

AI coding agents like Claude and Codex are helping EE teams turn concepts into tested hardware in weeks, not months, without adding a new vendor or software dependency.

An EE partner explains an electrical architecture decision to the client team during design review

Choosing an EE partner is a program risk decision, not a staffing decision. Early architecture choices carry through to certification, and the wrong partner can cost far more than their hourly rate suggests.

PCB stack-up planning happens here, as an engineer reviews routed copper layers on a wide monitor

PCB stack-up shapes signal integrity, EMC performance, and manufacturability long before layout begins. Getting layers and reference planes right avoids costly redesigns later.